The endocannabinoid system drives neural progenitor proliferation

By T. Aguado, K. Monory, Javier Palazuelos, Nephi Stella, Benjamin F. Cravatt, Beat Lutz, Giovanni Marsicano, Z. Kokaia, Manuel Guzmán, I. Galve-Roperh. The FASEB Journal, 2005

1,214 citations recorded by the source corpus.

Subfields: Cognitive Neuroscience, Pharmacology, Surgery

View Paper: https://www.semanticscholar.org/paper/aaa134f8d4d196c809ca0f1638273b0f2a6d6f91

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cognitive Neuroscience

1. George Kunos

In Pharmacology

1. P. Pacher
2. S. Batkai
3. George Kunos

In Surgery

1. P. Pacher
2. S. Batkai
3. George Kunos

Citations in the corpus

• Recent advances in biomaterials for 3D scaffolds: A review (2019, background): “Moreover, various studies demonstrated improvement in biological and physicochemical properties of mesoporous bioactive glass (MBG) scaffolds by incorporation inorganic therapeutic components such as Sr [93], Zn, Mg [94,95], Zr [96], Ga [97], or B [98].”
• Neurobiological Interactions Between Stress and the Endocannabinoid System (2016, positive): “…work has shown that elevating AEA signaling and promoting CB1 receptor signaling is capable of promoting cell proliferation and neurogenesis (Aguado et al, 2005; Jiang et al, 2005), these findings imply that impairments in AEA and/or CB1 receptor signaling from chronic stress could result…”
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy (2006, positive): “It has been recently demonstrated that the endocannabinoid system drives neural progenitor cell proliferation (Aguado et al., 2005, 2006), and cannabinoids promote neurogenesis (Berghuis et al., 2005; Jiang et al., 2005).”